Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults
Author(s) -
Amy Jones,
Eoin P. Flanagan,
Sean J. Pittock,
Jay Mandrekar,
Scott D.Z. Eggers,
J. Eric Ahlskog,
Andrew McKeon
Publication year - 2015
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2015.2378
Subject(s) - cerebellar ataxia , ataxia , medicine , neuroscience , cerebellum , psychology
Classic Purkinje cell cytoplasmic antibody type 1 (PCA-1, or anti-Yo) paraneoplastic cerebellar ataxia has a poor prognosis, yet little has been published otherwise regarding treatment responses and outcomes among patients with autoimmune cerebellar ataxia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom